“OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE”. 2015. Mediterranean Journal of Hematology and Infectious Diseases 7 (1): e2015003. https://doi.org/10.4084/mjhid.2015.003.